RXRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 15.75%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $10,096,309.56

Recursion Pharmaceuticals Insider Trading History Chart

Recursion Pharmaceuticals Share Price & Price History

^$6.03

▼ -0.15 (-2.43%)

As of 11/18/2024 04:05 PM ET

Days: 30 | 90 | 365

Wall St Legend Issues No. 1 Melt-Up Stock Pick

From Stansberry Research | Ad

Investors poured a staggering $56 billion into U.S. stock funds in just one week — the second-largest inflow since 2008... Nearly 50% of investors now describe themselves as bullish — the highest sentiment level since 2022...

Click here to watch Whitney Tilson's full market briefing and claim your free stock pick today.

Recursion Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/13/2024	Michael Secora	CFO	Sell	15,000	$7.66	$114,900.00	1,499,631
11/12/2024	Blake Borgeson	Director	Sell	11,447	$7.64	$87,455.08	7,066,113
10/29/2024	Blake Borgeson	Director	Sell	11,447	$6.72	$76,923.84	7,077,560
10/24/2024	Tina Marriott	COO	Sell	6,000	$6.31	$37,860.00	521,138
10/15/2024	Blake Borgeson	Director	Sell	11,447	$6.67	$76,351.49	7,089,007
10/8/2024	Michael Secora	CFO	Sell	15,000	$6.32	$94,800.00	1,426,506
10/2/2024	Christopher Gibson	CEO	Sell	20,000	$6.16	$123,200.00	762,656
10/1/2024	Blake Borgeson	Director	Sell	11,447	$6.22	$71,200.34	7,098,428
9/26/2024	Tina Marriott	COO	Sell	6,000	$7.00	$42,000.00	521,138
9/17/2024	Blake Borgeson	Director	Sell	11,447	$6.84	$78,297.48	7,109,875
9/10/2024	Michael Secora	CFO	Sell	15,000	$6.17	$92,550.00	1,377,756
9/4/2024	Christopher Gibson	CEO	Sell	20,000	$6.04	$120,800.00	762,656
9/3/2024	Blake Borgeson	Director	Sell	11,447	$6.27	$71,772.69	7,121,322
8/29/2024	Tina Marriott	COO	Sell	6,000	$7.56	$45,360.00	521,138
8/20/2024	Blake Borgeson	Director	Sell	11,447	$7.12	$81,502.64	7,132,769
8/13/2024	Michael Secora	CFO	Sell	15,000	$6.35	$95,250.00	1,340,968
8/7/2024	Christopher Gibson	CEO	Sell	30,000	$7.10	$213,000.00	758,738
8/6/2024	Blake Borgeson	Director	Sell	11,447	$6.82	$78,068.54	7,144,216
7/25/2024	Tina Marriott	COO	Sell	6,000	$8.13	$48,780.00	535,457
7/23/2024	Blake Borgeson	Director	Sell	11,447	$8.48	$97,070.56	7,155,663
7/10/2024	Christopher Gibson	CEO	Sell	50,000	$7.48	$374,000.00	758,738
7/9/2024	Blake Borgeson	Director	Sell	11,447	$7.32	$83,792.04	7,167,110
7/9/2024	Michael Secora	CFO	Sell	15,000	$7.32	$109,800.00	1,292,218
6/27/2024	Tina Marriott	COO	Sell	6,000	$7.21	$43,260.00	535,457
6/25/2024	Blake Borgeson	Director	Sell	11,447	$9.51	$108,860.97	7,177,116
6/13/2024	Michael Secora	CFO	Sell	15,000	$9.32	$139,800.00	1,243,468
6/11/2024	Blake Borgeson	Director	Sell	11,447	$8.45	$96,727.15	7,188,563
6/5/2024	Christopher Gibson	CEO	Sell	50,000	$8.42	$421,000.00	758,738
5/30/2024	Tina Marriott	COO	Sell	3,000	$8.78	$26,340.00	535,457
5/28/2024	Blake Borgeson	Director	Sell	11,447	$9.17	$104,968.99	7,186,913
5/1/2024	Christopher Gibson	CEO	Sell	50,000	$7.73	$386,500.00	863,524
4/30/2024	Blake Borgeson	Director	Sell	11,447	$7.95	$91,003.65	7,218,414
4/25/2024	Tina Marriott	COO	Sell	3,000	$7.67	$23,010.00	543,231
4/17/2024	Michael Secora	CFO	Sell	23,124	$7.58	$175,279.92	1,231,055
4/16/2024	Blake Borgeson	Director	Sell	11,447	$7.66	$87,684.02	7,229,861
4/3/2024	Christopher Gibson	CEO	Sell	40,000	$8.84	$353,600.00	978,524
4/2/2024	Blake Borgeson	Director	Sell	11,447	$8.82	$100,962.54	7,241,308
3/28/2024	Christopher Gibson	CEO	Sell	40,000	$10.10	$404,000.00	1,043,524
3/21/2024	Tina Marriott	COO	Sell	8,000	$10.75	$86,000.00	639,982
3/19/2024	Blake Borgeson	Director	Sell	20,054	$10.79	$216,382.66	7,252,755
3/13/2024	Michael Secora	CFO	Sell	25,000	$11.03	$275,750.00	1,204,179
3/6/2024	Christopher Gibson	CEO	Sell	36,319	$11.86	$430,743.34	1,108,524
3/5/2024	Blake Borgeson	Director	Sell	20,054	$12.06	$241,851.24	7,272,809
2/22/2024	Tina Marriott	COO	Sell	8,000	$14.89	$119,120.00	639,982
2/20/2024	Blake Borgeson	Director	Sell	20,054	$12.32	$247,065.28	7,292,863
2/13/2024	Michael Secora	CFO	Sell	25,000	$9.86	$246,500.00	1,173,851
2/7/2024	Christopher Gibson	CEO	Sell	48,272	$9.22	$445,067.84	774,703
2/6/2024	Blake Borgeson	Director	Sell	11,447	$9.30	$106,457.10	7,312,917
1/25/2024	Tina Marriott Larson	COO	Sell	8,000	$10.35	$82,800.00	414,548
1/23/2024	Blake Borgeson	Director	Sell	20,054	$10.58	$212,171.32	7,324,364
1/16/2024	Michael Secora	CFO	Sell	25,000	$10.45	$261,250.00	968,514
1/16/2024	Shafique Virani	Insider	Sell	18,000	$10.93	$196,740.00	136,748
1/9/2024	Dean Y. Li	Director	Sell	29,000	$13.66	$396,140.00	421,000
1/3/2024	Christopher Gibson	CEO	Sell	30,853	$9.49	$292,794.97	791,725
12/26/2023	Blake Borgeson	Director	Sell	20,054	$10.63	$213,174.02	7,364,472
12/15/2023	Shafique Virani	Insider	Sell	18,000	$9.60	$172,800.00	136,748
12/14/2023	Zavain Dar	Director	Sell	20,141	$9.00	$181,269.00	53,823
12/12/2023	Blake Borgeson	Director	Sell	11,447	$7.40	$84,707.80	7,384,526
12/12/2023	Michael Secora	CFO	Sell	25,000	$7.39	$184,750.00	943,514
12/6/2023	Christopher Gibson	CEO	Sell	59,829	$7.49	$448,119.21	791,328
11/28/2023	Blake Borgeson	Director	Sell	11,447	$6.72	$76,923.84	7,395,973
11/16/2023	Tina Marriott Larson	COO	Sell	3,000	$6.76	$20,280.00	413,404
11/15/2023	Shafique Virani	Insider	Sell	18,000	$6.51	$117,180.00	140,351
11/14/2023	Blake Borgeson	Director	Sell	8,885	$6.32	$56,153.20	7,407,420
11/14/2023	Michael Secora	CFO	Sell	25,000	$6.32	$158,000.00	925,686
11/1/2023	Christopher Gibson	CEO	Sell	37,177	$5.20	$193,320.40	836,820
10/31/2023	Blake Borgeson	Director	Sell	8,885	$5.27	$46,823.95	7,416,305
10/26/2023	Tina Marriott Larson	COO	Sell	3,000	$5.63	$16,890.00	418,782
10/17/2023	Blake Borgeson	Director	Sell	8,885	$6.58	$58,463.30	7,425,190
10/16/2023	Shafique Virani	Insider	Sell	18,000	$6.30	$113,400.00	140,351
10/10/2023	Michael Secora	CFO	Sell	25,000	$7.07	$176,750.00	900,686
10/4/2023	Christopher Gibson	CEO	Sell	59,794	$7.21	$431,114.74	842,747
10/3/2023	Blake Borgeson	Director	Sell	8,885	$7.29	$64,771.65	7,434,075
9/28/2023	Tina Marriott Larson	COO	Sell	3,000	$7.72	$23,160.00	418,782
9/19/2023	Blake Borgeson	Director	Sell	8,885	$8.36	$74,278.60	7,442,960
9/15/2023	Shafique Virani	Insider	Sell	18,000	$8.66	$155,880.00	140,351
9/13/2023	Michael Secora	CFO	Sell	25,000	$8.69	$217,250.00	888,186
9/6/2023	Christopher Gibson	CEO	Sell	33,765	$8.78	$296,456.70	871,291
9/5/2023	Blake Borgeson	Director	Sell	8,885	$8.79	$78,099.15	7,451,845
8/24/2023	Tina Marriott Larson	COO	Sell	3,000	$8.66	$25,980.00	418,782
8/22/2023	Blake Borgeson	Director	Sell	8,885	$8.91	$79,165.35	7,460,730
8/16/2023	Michael Secora	CFO	Sell	25,000	$8.90	$222,500.00	863,186
8/15/2023	Shafique Virani	Insider	Sell	18,000	$9.25	$166,500.00	140,351
8/8/2023	Blake Borgeson	Director	Sell	17,770	$11.16	$198,313.20	7,469,615
8/2/2023	Christopher Gibson	CEO	Sell	65,015	$13.04	$847,795.60	890,719
7/27/2023	Tina Marriott Larson	COO	Sell	8,000	$13.62	$108,960.00	424,160
7/26/2023	Shafique Virani	Insider	Sell	20,000	$14.41	$288,200.00	143,954
7/25/2023	Blake Borgeson	Director	Sell	18,719	$14.61	$273,484.59	7,487,385
7/18/2023	Michael Secora	CFO	Sell	25,000	$13.63	$340,750.00	830,413
7/17/2023	Shafique Virani	Insider	Sell	30,000	$11.72	$351,600.00	143,954
7/13/2023	Terry-Ann Burrell	Director	Sell	8,275	$12.59	$104,182.25	54,847
7/12/2023	Christopher Gibson	CEO	Sell	31,818	$13.14	$418,088.52	915,810
7/11/2023	Blake Borgeson	Director	Sell	8,885	$6.89	$61,217.65	7,520,104
6/29/2023	Tina Marriott Larson	COO	Sell	3,000	$7.49	$22,470.00	424,160
6/27/2023	Blake Borgeson	Director	Sell	8,885	$7.39	$65,660.15	7,528,989
6/13/2023	Blake Borgeson	Director	Sell	15,485	$9.98	$154,540.30	7,525,262
6/13/2023	Michael Secora	CFO	Sell	25,000	$9.93	$248,250.00	805,413
6/7/2023	Christopher Gibson	CEO	Sell	56,436	$9.05	$510,745.80	916,378
6/1/2023	Shafique Virani	Insider	Sell	25,000	$8.58	$214,500.00	161,819
5/31/2023	Tina Marriott Larson	COO	Sell	3,000	$8.63	$25,890.00	424,160
5/30/2023	Blake Borgeson	Director	Sell	8,885	$8.79	$78,099.15	7,540,747
5/16/2023	Blake Borgeson	Director	Sell	8,885	$5.09	$45,224.65	7,549,632
5/3/2023	Christopher Gibson	CEO	Sell	33,073	$4.71	$155,773.83	953,225
4/18/2023	Blake Borgeson	Director	Sell	8,885	$5.93	$52,688.05	7,558,517
4/5/2023	Christopher Gibson	CEO	Sell	13,327	$6.46	$86,092.42	946,710
4/4/2023	Blake Borgeson	Director	Sell	8,885	$6.53	$58,019.05	7,567,402
3/21/2023	Blake Borgeson	Director	Sell	8,885	$7.40	$65,749.00	7,576,287
3/8/2023	Christopher Gibson	CEO	Sell	70,890	$8.10	$574,209.00	963,787
3/7/2023	Blake Borgeson	Director	Sell	8,885	$8.33	$74,012.05	7,585,172
3/2/2023	Christopher Gibson	CEO	Sell	18,500	$7.92	$146,520.00	940,927
2/27/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	52,500	$7.69	$403,725.00	12,869,423
2/23/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	51,864	$7.79	$404,020.56	12,707,805
2/23/2023	Tina Marriott Larson	COO	Sell	8,000	$7.82	$62,560.00	427,844
2/21/2023	Blake Borgeson	Director	Sell	8,885	$7.73	$68,681.05	7,594,057
2/21/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	94,418	$7.74	$730,795.32	12,605,000
2/16/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	42,682	$7.90	$337,187.80	12,447,200
2/15/2023	Shafique Virani	Insider	Sell	7,486	$8.33	$62,358.38	189,846
2/14/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	6,300	$7.95	$50,085.00	12,404,518
2/10/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	11,000	$7.98	$87,780.00	12,365,744
2/7/2023	Blake Borgeson	Director	Sell	8,885	$8.81	$78,276.85	7,602,942
1/26/2023	Tina Marriott Larson	COO	Sell	8,000	$8.07	$64,560.00	203,654
1/25/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	24,526	$7.88	$193,264.88	12,346,258
1/24/2023	Blake Borgeson	Director	Sell	8,885	$8.71	$77,388.35	7,611,827
1/17/2023	Shafique Virani	Insider	Sell	10,000	$9.16	$91,600.00	73,160
1/10/2023	Blake Borgeson	Director	Sell	8,885	$7.69	$68,325.65	7,620,712
1/9/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	76,046	$7.64	$580,991.44	12,252,214
1/5/2023	Christopher Gibson	CEO	Sell	18,500	$7.39	$136,715.00	525,805
1/5/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	80,035	$7.38	$590,658.30	12,107,215
1/3/2023	Mubadala Investment Co Pjsc	Major Shareholder	Buy	141,646	$7.50	$1,062,345.00	11,935,288
12/29/2022	Tina Marriott Larson	COO	Sell	8,000	$7.70	$61,600.00	203,654
12/27/2022	Blake Borgeson	Director	Sell	8,885	$7.25	$64,416.25	7,628,272
12/15/2022	Shafique Virani	Insider	Sell	10,000	$8.85	$88,500.00	78,160
12/13/2022	Blake Borgeson	Director	Sell	8,885	$8.96	$79,609.60	7,637,157
12/1/2022	Christopher Gibson	CEO	Sell	37,210	$9.02	$335,634.20	582,805
11/29/2022	Blake Borgeson	Director	Sell	8,885	$8.75	$77,743.75	7,646,042
11/17/2022	Tina Marriott Larson	COO	Sell	16,000	$10.96	$175,360.00	203,654
11/16/2022	Blake Borgeson	Director	Sell	17,770	$11.12	$197,602.40	7,654,927
11/15/2022	Shafique Virani	Insider	Sell	10,000	$12.31	$123,100.00	83,160
11/3/2022	Christopher Gibson	CEO	Sell	36,693	$10.00	$366,930.00	576,016
10/27/2022	Tina Marriott Larson	COO	Sell	16,000	$10.72	$171,520.00	205,107
10/14/2022	Shafique Virani	Insider	Sell	10,000	$10.92	$109,200.00	88,773
10/6/2022	Christopher Gibson	CEO	Sell	36,053	$11.58	$417,493.74	562,959
9/29/2022	Tina Marriott Larson	COO	Sell	16,000	$10.86	$173,760.00	205,107
9/15/2022	Shafique Virani	Insider	Sell	10,000	$13.36	$133,600.00	93,773
8/16/2022	Shafique Virani	Insider	Sell	30,000	$12.61	$378,300.00	98,773
8/16/2022	Tina Marriott Larson	COO	Sell	16,000	$12.60	$201,600.00	295,107
8/4/2022	Christopher Gibson	CEO	Sell	36,825	$9.49	$349,469.25	541,829
7/7/2022	Christopher Gibson	CEO	Sell	37,114	$9.05	$335,881.70	528,904
6/2/2022	Christopher Gibson	CEO	Sell	39,690	$6.09	$241,712.10	516,268
5/4/2022	Christopher Gibson	CEO	Sell	31,830	$6.49	$206,576.70	511,972
4/28/2022	Christopher Gibson	CEO	Sell	37,605	$6.09	$229,014.45	469,608
4/21/2022	Christopher Gibson	CEO	Sell	37,155	$6.31	$234,448.05	420,146
4/18/2022	Christopher Gibson	CEO	Sell	35,836	$6.84	$245,118.24	394,791
4/14/2022	Christopher Gibson	CEO	Sell	34,517	$7.56	$260,948.52	368,117
4/7/2022	Christopher Gibson	CEO	Sell	36,718	$6.54	$240,135.72	314,534
4/5/2022	Christopher Gibson	CEO	Sell	34,472	$7.43	$256,126.96	288,742
3/14/2022	Christopher Gibson	CEO	Sell	230,000	$6.28	$1,444,400.00
3/11/2022	Christopher Gibson	CEO	Sell	100,000	$6.95	$695,000.00
3/7/2022	Christopher Gibson	CEO	Sell	300,000	$7.30	$2,190,000.00
2/22/2022	Christopher Gibson	CEO	Sell	100,000	$10.22	$1,022,000.00
1/31/2022	Christopher Gibson	CEO	Sell	19,858	$11.73	$232,934.34
1/13/2022	Christopher Gibson	CEO	Sell	87,000	$14.33	$1,246,710.00
1/4/2022	Blake Borgeson	Director	Sell	9,625	$18.03	$173,538.75
12/21/2021	Blake Borgeson	Director	Sell	9,625	$18.75	$180,468.75
12/16/2021	Christopher Gibson	CEO	Sell	200	$20.00	$4,000.00
12/16/2021	Tina Marriott Larson	COO	Sell	2,500	$18.74	$46,850.00
12/13/2021	Christopher Gibson	CEO	Sell	100	$20.02	$2,002.00
12/9/2021	Christopher Gibson	CEO	Sell	1,086	$20.01	$21,730.86
12/7/2021	Blake Borgeson	Director	Sell	9,625	$20.32	$195,580.00
12/7/2021	Christopher Gibson	CEO	Sell	3,125	$20.51	$64,093.75
11/19/2021	Dean Y. Li	Director	Sell	13,474	$20.20	$272,174.80
11/18/2021	Tina Marriott Larson	COO	Sell	2,500	$18.92	$47,300.00
11/17/2021	Dean Y. Li	Director	Sell	5,626	$20.04	$112,745.04

A huge crack is forming in the US economy

From Wide Moat Research | Ad

Former Trump Advisor Warning: “An Economic Rupture Is Coming” The legendary financier Brad Thomas served on Trump’s advisory board for years. Now he’s stepping forward with a terrifying new warning. “Even the rich aren’t safe,” he says. “I’m taking steps to protect my family.”

Learn how to protect yourself too, click here.

SEC Filings (Institutional Ownership Changes) for Recursion Pharmaceuticals (NASDAQ:RXRX)

89.06% of Recursion Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Recursion Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	5,431,911	$35.80M	0.0%	+13.7%	1.932%
11/15/2024	Barclays PLC	697,432	$4.60M	0.0%	+53.9%	0.248%
11/15/2024	Wellington Management Group LLP	105,018	$0.69M	0.0%	N/A	0.037%
11/15/2024	State Street Corp	12,870,272	$84.82M	0.0%	+47.1%	4.578%
11/15/2024	Stifel Financial Corp	161,978	$1.07M	0.0%	+48.8%	0.058%
11/15/2024	HighTower Advisors LLC	24,144	$0.16M	0.0%	-35.1%	0.009%
11/15/2024	Benjamin Edwards Inc.	162,481	$1.07M	0.0%	+13,196.3%	0.058%
11/15/2024	Erste Asset Management GmbH	33,500	$0.23M	0.0%	N/A	0.012%
11/14/2024	Bellevue Group AG	392,881	$2.59M	0.0%	-7.7%	0.140%
11/14/2024	Arete Wealth Advisors LLC	11,656	$77K	0.0%	N/A	0.004%
11/14/2024	Rockefeller Capital Management L.P.	66,639	$0.44M	0.0%	N/A	0.024%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	2,140,750	$14.11M	0.0%	+2.1%	0.762%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	52,530	$0.35M	0.0%	+5.3%	0.019%
11/14/2024	MetLife Investment Management LLC	136,541	$0.90M	0.0%	+13.7%	0.049%
11/13/2024	FMR LLC	8,363,530	$55.12M	0.0%	+2.1%	2.975%
11/13/2024	The Manufacturers Life Insurance Company	124,654	$0.82M	0.0%	+11.7%	0.044%
11/13/2024	Qsemble Capital Management LP	34,017	$0.22M	0.0%	N/A	0.012%
11/12/2024	Centaurus Financial Inc.	10,774	$71K	0.0%	N/A	0.004%
11/12/2024	Charles Schwab Investment Management Inc.	1,940,680	$12.79M	0.0%	+17.5%	0.690%
11/9/2024	Intech Investment Management LLC	52,953	$0.35M	0.0%	N/A	0.019%
11/7/2024	Quest Partners LLC	9,645	$64K	0.0%	-60.2%	0.003%
11/6/2024	KBC Group NV	7,602	$50K	0.0%	+79.9%	0.003%
11/6/2024	Pier 88 Investment Partners LLC	133,910	$0.88M	0.2%	+442.1%	0.048%
11/5/2024	Victory Capital Management Inc.	27,394	$0.18M	0.0%	+25.1%	0.010%
11/5/2024	Sumitomo Mitsui Trust Group Inc.	9,766,728	$64.36M	0.0%	-2.2%	3.474%
11/5/2024	Baillie Gifford & Co.	25,239,870	$166.33M	0.1%	-5.1%	8.979%
11/4/2024	Axxcess Wealth Management LLC	43,884	$0.29M	0.0%	+4.3%	0.016%
11/2/2024	Privium Fund Management B.V.	78,000	$0.51M	0.1%	+50.0%	0.028%
10/31/2024	ARK Investment Management LLC	32,769,186	$215.95M	2.0%	+16.4%	11.657%
10/31/2024	Principal Financial Group Inc.	22,160	$0.15M	0.0%	-37.5%	0.008%
10/30/2024	QRG Capital Management Inc.	18,263	$0.12M	0.0%	N/A	0.006%
10/29/2024	Clear Creek Financial Management LLC	12,313	$81K	0.0%	N/A	0.004%
10/29/2024	Chicago Partners Investment Group LLC	15,974	$0.10M	0.0%	N/A	0.006%
10/29/2024	Farther Finance Advisors LLC	6,404	$42K	0.0%	+176.9%	0.002%
10/25/2024	SteelPeak Wealth LLC	88,274	$0.58M	0.0%	+310.0%	0.031%
10/25/2024	China Universal Asset Management Co. Ltd.	52,905	$0.35M	0.0%	+95.6%	0.019%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	87,539	$0.61M	0.0%	+1,173.3%	0.037%
10/23/2024	Values First Advisors Inc.	60,223	$0.40M	0.2%	-2.5%	0.025%
10/23/2024	Cherry Creek Investment Advisors Inc.	57,340	$0.38M	0.2%	-38.6%	0.024%
10/23/2024	Brighton Jones LLC	13,562	$89K	0.0%	N/A	0.006%
10/22/2024	International Assets Investment Management LLC	84,682	$0.56M	0.0%	+527.3%	0.036%
10/22/2024	Private Advisor Group LLC	15,419	$0.10M	0.0%	+28.6%	0.005%
10/21/2024	Foundations Investment Advisors LLC	193,036	$1.27M	0.0%	+25.0%	0.081%
10/19/2024	Allspring Global Investments Holdings LLC	3,758	$25K	0.0%	N/A	0.002%
10/16/2024	IQ EQ FUND MANAGEMENT IRELAND Ltd	82,352	$0.54M	0.1%	+104.6%	0.035%
10/16/2024	Vontobel Holding Ltd.	10,600	$70K	0.0%	N/A	0.004%
10/15/2024	Oxinas Partners Wealth Management LLC	11,250	$74K	0.0%	-33.4%	0.005%
10/10/2024	Exchange Traded Concepts LLC	25,182	$0.17M	0.0%	+24.9%	0.009%
10/9/2024	San Luis Wealth Advisors LLC	10,500	$69K	0.0%	N/A	0.004%
10/7/2024	Green Alpha Advisors LLC	64,799	$0.43M	0.3%	+2.9%	0.027%
10/5/2024	Handelsbanken Fonder AB	69,500	$0.46M	0.0%	+33.4%	0.029%
10/3/2024	SG Americas Securities LLC	89,325	$0.59M	0.0%	+249.0%	0.032%
9/4/2024	Ghisallo Capital Management LLC	1,100,000	$8.25M	0.5%	N/A	0.391%
8/16/2024	Perceptive Advisors LLC	769,230	$5.77M	0.1%	N/A	0.324%
8/16/2024	Algert Global LLC	17,158	$0.13M	0.0%	N/A	0.007%
8/15/2024	Scientech Research LLC	140,295	$1.05M	0.2%	N/A	0.059%
8/15/2024	The Manufacturers Life Insurance Company	111,613	$0.84M	0.0%	+32.6%	0.047%
8/15/2024	Marathon Capital Management	175,220	$1.31M	0.3%	+1.6%	0.074%
8/15/2024	Employees Retirement System of Texas	50,351	$0.38M	0.0%	+13.4%	0.021%
8/14/2024	Xponance Inc.	13,132	$98K	0.0%	N/A	0.006%
8/14/2024	ProShare Advisors LLC	32,877	$0.25M	0.0%	-19.7%	0.014%
8/14/2024	Profund Advisors LLC	74,771	$0.56M	0.0%	-41.2%	0.031%
8/13/2024	Ensign Peak Advisors Inc	408,986	$3.07M	0.0%	+2.5%	0.172%
8/13/2024	Public Employees Retirement Association of Colorado	17,217	$0.13M	0.0%	N/A	0.007%
8/13/2024	Benjamin F. Edwards & Company Inc.	169,900	$1.27M	0.0%	+6,439.6%	0.071%
8/12/2024	Hsbc Holdings PLC	27,972	$0.21M	0.0%	+26.0%	0.012%
8/12/2024	Amalgamated Bank	7,152	$54K	0.0%	+52.4%	0.003%
8/12/2024	Lingotto Investment Management LLP	3,675,077	$27.56M	0.9%	+69.0%	1.546%
8/12/2024	E Fund Management Co. Ltd.	24,165	$0.18M	0.0%	-37.6%	0.010%
8/10/2024	Plancorp LLC	70,610	$0.53M	0.0%	+155.7%	0.030%
8/9/2024	Dimensional Fund Advisors LP	1,920,177	$14.40M	0.0%	-8.3%	0.808%
8/7/2024	Headlands Technologies LLC	23,092	$0.17M	0.0%	N/A	0.010%
8/7/2024	Daiwa Securities Group Inc.	7,868	$59K	0.0%	-29.0%	0.003%
8/6/2024	Quest Partners LLC	24,219	$0.18M	0.0%	+52.6%	0.010%
8/6/2024	Pier 88 Investment Partners LLC	24,700	$0.19M	0.0%	N/A	0.010%
8/6/2024	Mosley Wealth Management	14,746	$0.11M	0.1%	N/A	0.006%
8/6/2024	Los Angeles Capital Management LLC	32,755	$0.25M	0.0%	N/A	0.014%
8/5/2024	Arizona State Retirement System	47,691	$0.36M	0.0%	+11.1%	0.020%
8/5/2024	Victory Capital Management Inc.	21,891	$0.16M	0.0%	+13.5%	0.009%
8/2/2024	Commons Capital LLC	111,107	$0.83M	1.0%	N/A	0.047%
8/2/2024	Foundations Investment Advisors LLC	154,394	$1.16M	0.0%	+296.1%	0.065%
8/2/2024	Oxinas Partners Wealth Management LLC	16,900	$0.13M	0.1%	+38.0%	0.007%
8/1/2024	Rhumbline Advisers	281,348	$2.11M	0.0%	+24.1%	0.118%
8/1/2024	Hussman Strategic Advisors Inc.	105,000	$0.79M	0.2%	+150.0%	0.044%
8/1/2024	Privium Fund Management B.V.	52,000	$0.37M	0.1%	N/A	0.022%
8/1/2024	Interchange Capital Partners LLC	34,580	$0.27M	0.1%	+7.3%	0.015%
7/31/2024	Commonwealth Equity Services LLC	44,241	$0.33M	0.0%	+25.7%	0.019%
7/30/2024	International Assets Investment Management LLC	13,500	$0.10M	0.0%	N/A	0.006%
7/29/2024	Principal Financial Group Inc.	35,439	$0.27M	0.0%	-91.1%	0.015%
7/29/2024	IQ EQ FUND MANAGEMENT IRELAND Ltd	40,251	$0.30M	0.0%	N/A	0.017%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	49,863	$0.37M	0.0%	+39.3%	0.021%
7/26/2024	ARK Investment Management LLC	28,142,918	$211.07M	1.9%	+14.5%	11.842%
7/26/2024	Liontrust Investment Partners LLP	990,000	$7.43M	0.1%	+32.0%	0.417%
7/26/2024	Bank of New York Mellon Corp	1,060,804	$7.96M	0.0%	+20.3%	0.446%
7/25/2024	Baillie Gifford & Co.	26,589,936	$199.43M	0.2%	+10.5%	11.188%
7/19/2024	Hoylecohen LLC	45,522	$0.34M	0.0%	N/A	0.019%
7/19/2024	Sumitomo Mitsui Trust Holdings Inc.	9,987,030	$74.90M	0.1%	-3.6%	4.202%
7/17/2024	Midwest Financial Group LLC	12,019	$90K	0.1%	N/A	0.005%
7/17/2024	SteelPeak Wealth LLC	21,532	$0.16M	0.0%	N/A	0.009%
7/17/2024	180 Wealth Advisors LLC	17,455	$0.13M	0.0%	N/A	0.007%

Data available starting January 2016

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Today's Range

Now: $6.03

$5.90

$6.25

50 Day Range

MA: $6.66

$6.06

$7.84

52 Week Range

Now: $6.03

$5.89

$15.74

Volume

8,063,135 shs

Average Volume

5,763,038 shs

Market Capitalization

$1.70 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.81

Who are the company insiders with the largest holdings of Recursion Pharmaceuticals?: Recursion Pharmaceuticals' top insider investors include:
Mubadala Investment Co Pjsc (Major Shareholder)
Blake Borgeson (Director)
Michael Secora (CFO)
Christopher Gibson (CEO)
Tina Marriott (COO)
Tina Marriott Larson (COO)
Dean Y Li (Director)
Shafique Virani (Insider)
Terry-Ann Burrell (Director)
Zavain Dar (Director)
Learn More about top insider investors at Recursion Pharmaceuticals.
Who are the major institutional investors of Recursion Pharmaceuticals?: Recursion Pharmaceuticals' top institutional investors include:
ARK Investment Management LLC — 11.66%
Baillie Gifford & Co. — 8.98%
State Street Corp — 4.58%
Sumitomo Mitsui Trust Group Inc. — 3.47%
FMR LLC — 2.98%
Geode Capital Management LLC — 1.93%
Learn More about top institutional investors of Recursion Pharmaceuticals stock.
Which institutional investors are selling Recursion Pharmaceuticals stock?: Within the previous quarter, RXRX stock was sold by these institutional investors:
Baillie Gifford & Co.
Sumitomo Mitsui Trust Group Inc.
Cherry Creek Investment Advisors Inc.
Bellevue Group AG
Quest Partners LLC
Principal Financial Group Inc.
HighTower Advisors LLC
Oxinas Partners Wealth Management LLC
During the last year, company insiders that have sold Recursion Pharmaceuticals company stock include:
Mubadala Investment Co Pjsc (Major Shareholder)
Blake Borgeson (Director)
Michael Secora (CFO)
Christopher Gibson (CEO)
Tina Marriott (COO)
Tina Marriott Larson (COO)
Dean Y Li (Director)
Shafique Virani (Insider)
Learn More investors selling Recursion Pharmaceuticals stock.
Which institutional investors are buying Recursion Pharmaceuticals stock?: In the previous quarter, RXRX stock was purchased by institutional investors including:
ARK Investment Management LLC
State Street Corp
Geode Capital Management LLC
Charles Schwab Investment Management Inc.
Barclays PLC
FMR LLC
Benjamin Edwards Inc.
Pier 88 Investment Partners LLC